Citadel Advisors
ZVSA

Citadel Advisors’s ZyVersa Therapeutics ZVSA Stock Holding History

Citadel Advisors’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,499
Closed -$13.5K – 6918
2023
Q4 		$13.5K Buy
+1,499
New +$13.5K ﹤0.01% 5474